INOVIO PHARMACEUTICALS, INC.: accounts_receivable
| Value | {"amount": 2783264, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2019-03-31) |
| Status | current |
| Entity | INOVIO PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T10:22:44.993526+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/c41e0859-b337-486d-958e-0cd6769f0ff6
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001055726-19-000029 · Open the official SEC filing →Retrieved: 2026-08-19T10:22:44.993526+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001055726/accounts-receivable/2019-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/c41e0859-b337-486d-958e-0cd6769f0ff6
History
- no predecessors — first report